GlassScriptPhysician profile
Belinda Thompson
NPI 1639451024
$1,215.99
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $813 · 2022: $311 · 2023: $92.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $244.31 | 2021-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.67 | 2021-2023 | Lifevest |
| Sanofi-Aventis U.S. LLC | $132.87 | 2021-2023 | |
| Abbott Laboratories | $131.18 | 2021 | |
| Pfizer INC. | $125.97 | 2021 | |
| Astellas Pharma US INC | $113.81 | 2021 | |
| Amarin Pharma, INC. | $55.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $50.60 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $44.89 | 2021-2023 | Eliquis |
| Amgen INC. | $32.30 | 2021-2022 | |
| Esperion Therapeutics, INC. | $20.74 | 2021 | |
| Medtronic, INC. | $20.67 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.53 | 2021 | |
| Biotronik INC. | $16.12 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Belinda Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.